Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for Investors – Contact Levi & Korsinsky
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Verve Therapeutics, Inc. (“Verve Therapeutics” or the “Company”) (NASDAQ: VERV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Verve Therapeutics investors who were adversely affected by alleged securities fraud between August […]